These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 17329409

  • 1. Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study.
    Nergårdh AK, Rosenqvist M, Nordlander R, Frick M.
    Eur Heart J; 2007 Jun; 28(11):1351-7. PubMed ID: 17329409
    [Abstract] [Full Text] [Related]

  • 2. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M, Darpö B, Ostergren J, Rosenqvist M.
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [Abstract] [Full Text] [Related]

  • 3. Amiodarone after unsuccessful direct-current cardioversion of persistent atrial fibrillation.
    Kosior DA, Wozakowska-Kapłon B, Jasik M, Kiliszek M, Rabczenko D, Opolski G.
    Kardiol Pol; 2005 Dec; 63(6):585-92; discussion 593-4. PubMed ID: 16380855
    [Abstract] [Full Text] [Related]

  • 4. Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study.
    Almroth H, Höglund N, Boman K, Englund A, Jensen S, Kjellman B, Tornvall P, Rosenqvist M.
    Eur Heart J; 2009 Apr; 30(7):827-33. PubMed ID: 19202157
    [Abstract] [Full Text] [Related]

  • 5. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G, Prevention of Atrial Fibrillation after Cardioversion Investigators.
    Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned.
    Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, Harcombe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA.
    Am Heart J; 2006 Apr; 151(4):863.e1-6. PubMed ID: 16569550
    [Abstract] [Full Text] [Related]

  • 7. n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.
    Bianconi L, Calò L, Mennuni M, Santini L, Morosetti P, Azzolini P, Barbato G, Biscione F, Romano P, Santini M.
    Europace; 2011 Feb; 13(2):174-81. PubMed ID: 21059740
    [Abstract] [Full Text] [Related]

  • 8. n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study.
    Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M, Dei Cas L.
    Circulation; 2011 Sep 06; 124(10):1100-6. PubMed ID: 21844082
    [Abstract] [Full Text] [Related]

  • 9. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B, Straumann E, Bertel O.
    Int J Cardiol; 2005 Mar 18; 99(2):283-7. PubMed ID: 15749188
    [Abstract] [Full Text] [Related]

  • 10. Rapid conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.
    Geller JC, Egstrup K, Kulakowski P, Rosenqvist M, Jansson MA, Berggren A, Edvardsson N, Sager P, Crijns HJ.
    J Clin Pharmacol; 2009 Mar 18; 49(3):312-22. PubMed ID: 19129422
    [Abstract] [Full Text] [Related]

  • 11. Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation.
    Holmqvist F, Stridh M, Waktare JE, Sörnmo L, Olsson SB, Meurling CJ.
    Eur Heart J; 2006 Sep 18; 27(18):2201-7. PubMed ID: 16956916
    [Abstract] [Full Text] [Related]

  • 12. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].
    Larsen MT, Lyngborg K, Pedersen F, Corell P.
    Ugeskr Laeger; 2005 Sep 05; 167(36):3408-12. PubMed ID: 16159494
    [Abstract] [Full Text] [Related]

  • 13. Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion.
    Jong GP, Chang MH, Chang TC, Chou P, Fu CY, Tien LY, Chen CY, Ma TC.
    Chin Med J (Engl); 2006 Dec 20; 119(24):2030-5. PubMed ID: 17199952
    [Abstract] [Full Text] [Related]

  • 14. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME, Van Noord T, Crijns HJ, Van Veldhuisen DJ, Veeger NJ, Bosker HA, Wiesfeld AC, Van den Berg MP, Ranchor AV, Van Gelder IC.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):1001-9. PubMed ID: 16949494
    [Abstract] [Full Text] [Related]

  • 15. A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion.
    Torp-Pedersen C, Raev DH, Dickinson G, Butterfield NN, Mangal B, Beatch GN.
    Circ Arrhythm Electrophysiol; 2011 Oct 05; 4(5):637-43. PubMed ID: 21841207
    [Abstract] [Full Text] [Related]

  • 16. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
    Ari H, Binici S, Ari S, Akkaya M, Koca V, Bozat T, Gürdoğan M.
    Turk Kardiyol Dern Ars; 2008 Oct 05; 36(7):456-60. PubMed ID: 19155659
    [Abstract] [Full Text] [Related]

  • 17. Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling.
    Zohar P, Kovacic M, Brezocnik M, Podbregar M.
    Europace; 2005 Sep 05; 7(5):500-7. PubMed ID: 16087117
    [Abstract] [Full Text] [Related]

  • 18. Signal-averaged P wave reflects change in atrial electrophysiological substrate afforded by verapamil following cardioversion from atrial fibrillation.
    Redfearn DP, Skanes AC, Lane J, Stafford PJ.
    Pacing Clin Electrophysiol; 2006 Oct 05; 29(10):1089-95. PubMed ID: 17038141
    [Abstract] [Full Text] [Related]

  • 19. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML, Cianfrocca C, Pasceri V, Bianconi L, Auriti A, Calo L, Lamberti F, Castro A, Pandozi C, Palamara A, Santini M.
    Am J Cardiol; 2007 May 15; 99(10):1421-4. PubMed ID: 17493472
    [Abstract] [Full Text] [Related]

  • 20. One-year outcome of cardioversion of atrial fibrillation in patients with mitral stenosis after percutaneous balloon mitral valvuloplasty.
    Krittayaphong R, Chotinaiwatarakul C, Phankingthongkum R, Panchavinnin P, Tresukosol D, Jakrapanichakul D, Sriratanasathavorn C, Kitrattana B, Kangkagate C.
    Am J Cardiol; 2006 Apr 01; 97(7):1045-50. PubMed ID: 16563913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.